I believe the Market is informing us as to the extent this misinformation of caution regarding any potential of RVX 208 cardio toxicity was and may still be out there. I dont believe at all that Peros et al  are unaware and or uneducated of the enormous difference in selective vs pan inhibition in drug development.  Regardless this Trojan Horse is now burning brightly outside the gate, and the share price has moved up some. In my opinion we will be further informed if it continues to do so today. I also believe that more of these type of “challenges” will occur as the Prize is immense, however the gravitas of the likes of Drs Kalanter , Libby, and Ray etc.. along with our Company are more than up to it.